Ocrevus
Drug timelines are a Plus or Pro feature.
40 regulatory and trial events tracked for Ocrevus, covering 2009-09-03 to 2026-08-20. Get the full timeline:
Most recent: EMA Authorised: Ocrevus (ocrelizumab) — Roche Registration GmbH
40 regulatory and trial events tracked for Ocrevus, covering 2009-09-03 to 2026-08-20. Get the full timeline:
Most recent: EMA Authorised: Ocrevus (ocrelizumab) — Roche Registration GmbH